ReviewFrontiers in oncology2020

Discoidin Domain Receptors in Melanoma: Potential Therapeutic Targets to Overcome MAPK Inhibitor Resistance.

Coralie Reger de Moura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.